SIG - Quantitative Systems Pharmacology (QSP)

This event aimed to define minimum evaluation criteria for QSP virtual populations used in regulatory submissions, establishing clear credibility assessment guidelines that will shape the future of QSP modeling.

Featured Presentations

The workshop features an impressive lineup of speakers sharing real-world experiences with VPOPs in regulatory submissions:

• Steve Chang: "Virtual Population Assessment Landscape: Where are we thus far?"
• Rohit Rao, Pfizer: "Learn-Predict-Confirm: Development and Qualification of QSP Virtual Populations for COVID-19 Therapeutics"
• Mengdi Tao, Sanofi: "Credibility of QSP Virtual Populations in Rare Disease Drug Development"
• Yili Qian, BMS: "Developing Virtual Populations for QSP Models: A Workflow Illustrated by an Immune Checkpoint Inhibitor Case Study"

Discussion Leaders

• Lourdes Cucurull-Sanchez: Best Practices from Experience
• Jingqi Gong & Monica Susilo: Digital Twins and Future Directions